AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18413439 — intervention group
Group type: EXPERIMENTAL
Intervention: Local cold therapy with glucocorticoids (GC)
Number of subjects: 55
Study 17331915 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal emergency response systems (PERS)
Number of subjects: 86
Study 17331915 — intervention group
Group type: COMPARATOR
Intervention: Standard ED discharge planning
Number of subjects: 86
Study 15389223 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled phlebotomy for graded reduction of iron stores
Number of subjects: 0
Study 15389223 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 11605924 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory epidural analgesia with ambulation
Number of subjects: 160
Study 11605924 — intervention group
Group type: COMPARATOR
Intervention: Ambulatory epidural analgesia without ambulation
Number of subjects: 160
Study 9806676 — intervention group
Group type: EXPERIMENTAL
Intervention: Underwater seal technique
Number of subjects: 20
Study 9806676 — intervention group
Group type: COMPARATOR
Intervention: Cuff inflated to a pressure of 25 cm H2O
Number of subjects: 20
Study 7912948 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 1.5 mg and atropine 0.5 mg
Number of subjects: 80
Study 7912948 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous recovery (Control)
Number of subjects: 80
Study 2810159 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver function tests performed on patients with confirmed cholecystitis (206/270)
Number of subjects: 311
Study 2810159 — intervention group
Group type: COMPARATOR
Intervention: Liver function tests performed on patients with other diagnoses (64/270)
Number of subjects: 311
Study 2810159 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal liver function tests in suspected cholecystitis
Number of subjects: 311
Study 2810159 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of ductal calculi in proven cases of cholecystitis
Number of subjects: 311
Study 31395176 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative virtual reality (VR) experience of 3D reconstructed MRIs
Number of subjects: 0
Study 31395176 — intervention group
Group type: COMPARATOR
Intervention: Standard preoperative information about MRI (NR group)
Number of subjects: 0
Study 29442459 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini Nutritional Assessment (MNA)
Number of subjects: 85
Study 29442459 — intervention group
Group type: EXPERIMENTAL
Intervention: Glasgow Prognostic Score (GPS)
Number of subjects: 85
Study 29442459 — intervention group
Group type: EXPERIMENTAL
Intervention: MNA test
Number of subjects: 85
Study 29442459 — intervention group
Group type: EXPERIMENTAL
Intervention: GPS
Number of subjects: 85
Study 26169131 — intervention group
Group type: EXPERIMENTAL
Intervention: Helpful neighbors
Number of subjects: 2295
Study 26169131 — intervention group
Group type: COMPARATOR
Intervention: Unhelpful neighbors
Number of subjects: 2295
Study 26169131 — intervention group
Group type: EXPERIMENTAL
Intervention: Living in U.S. Census tract with low educational achievement
Number of subjects: 2295
Study 26169131 — intervention group
Group type: EXPERIMENTAL
Intervention: Living in Census tracts with high poverty
Number of subjects: 2295
Study 24237357 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilisation splints (SS)
Number of subjects: 23
Study 24237357 — intervention group
Group type: COMPARATOR
Intervention: Palatal splint (PS)
Number of subjects: 23
Study 24237357 — intervention group
Group type: COMPARATOR
Intervention: Baseline (no splint)
Number of subjects: 23
Study 21997317 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar vessel sealer (BVS)
Number of subjects: 114
Study 17933588 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumiracoxib 400 mg
Number of subjects: 364
Study 17933588 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib 400 mg
Number of subjects: 364
Study 17933588 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 364
Study 16491317 — intervention group
Group type: COMPARATOR
Intervention: Cold face test (CFT) using three cold packs at 0.5 degrees C applied to the face.
Number of subjects: 12
Study 16491317 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold face test (CFT) in patients with baroreflex impairment.
Number of subjects: 12
Study 12781313 — intervention group
Group type: EXPERIMENTAL
Intervention: Consultation‐Liaison Psychiatry (C‐L Psychiatry) intervention; early screening with systematic multidisciplinary management for emotional disorders.
Number of subjects: 176
Study 12781313 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 176
Study 10940543 — intervention group
Group type: EXPERIMENTAL
Intervention: Pergolide 0.05 mg bid
Number of subjects: 358
Study 10940543 — intervention group
Group type: EXPERIMENTAL
Intervention: Pergolide 0.25 mg bid
Number of subjects: 358
Study 10940543 — intervention group
Group type: EXPERIMENTAL
Intervention: Pergolide (both doses)
Number of subjects: 358
Study 10940543 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 358
Study 9314792 — intervention group
Group type: EXPERIMENTAL
Intervention: Condom availability program in New York City public high schools
Number of subjects: 12857
Study 9314792 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-risk students in New York City (three or more sexual partners in the past 6 months)
Number of subjects: 12857
Study 9314792 — intervention group
Group type: COMPARATOR
Intervention: Condom availability program
Number of subjects: 12857
Study 7755466 — intervention group
Group type: EXPERIMENTAL
Intervention: ISIS tutorial program (interactive session with computer for 30 to 60 minutes)
Number of subjects: 158
Study 7755466 — intervention group
Group type: COMPARATOR
Intervention: Usual education (contacts with physicians, nurses, dieticians, health-oriented booklets)
Number of subjects: 158
Study 7755466 — intervention group
Group type: EXPERIMENTAL
Intervention: ISIS tutorial program (for patients with initial scores ≤ 16)
Number of subjects: 158
Study 7755466 — intervention group
Group type: COMPARATOR
Intervention: Usual education (for patients with initial scores ≤ 16)
Number of subjects: 158
Study 3291787 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined measles, mumps, and rubella vaccine
Number of subjects: 319
Study 3291787 — intervention group
Group type: COMPARATOR
Intervention: Single component measles vaccine
Number of subjects: 319
Study 31313720 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal CPAP (SuperNO2VA) at 10 cmH2O, oxygen flow rate of 15 l/min
Number of subjects: 136
Study 31313720 — intervention group
Group type: COMPARATOR
Intervention: Oxygen via nasal cannula at 5 l/min
Number of subjects: 136
Study 28198722 — intervention group
Group type: EXPERIMENTAL
Intervention: Video testimonial (VM) included in survey
Number of subjects: 1366
Study 28198722 — intervention group
Group type: COMPARATOR
Intervention: Stand-alone Physician Orders for Life-Sustaining Treatment (POLST) and living will (LW) documents
Number of subjects: 1366
Study 26164820 — intervention group
Group type: EXPERIMENTAL
Intervention: Metacognition (measured with the Metacognitive Assessment Scale‐Abbreviated)
Number of subjects: 53
Study 26164820 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline negative symptoms (measured with the Positive and Negative Syndrome Scale)
Number of subjects: 53
Study 26164820 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurocognition (measured with the MATRICS battery)
Number of subjects: 53
Study 26164820 — intervention group
Group type: EXPERIMENTAL
Intervention: Affect recognition (measured with the Bell Lysaker Emotion Recognition Task)
Number of subjects: 53
Study 26164820 — intervention group
Group type: EXPERIMENTAL
Intervention: Defeatist beliefs (measured with the Recovery Assessment Scale)
Number of subjects: 53
Study 23556549 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg IV pre-treatment
Number of subjects: 0
Study 23556549 — intervention group
Group type: COMPARATOR
Intervention: Standard NAC regimen (20.25 hours)
Number of subjects: 0
Study 23556549 — intervention group
Group type: COMPARATOR
Intervention: Modified NAC regimen (12 hours)
Number of subjects: 0
Study 23556549 — intervention group
Group type: EXPERIMENTAL
Intervention: Both NAC regimens
Number of subjects: 0
Study 21534677 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational plus behavioral skills intervention
Number of subjects: 1563
Study 21534677 — intervention group
Group type: COMPARATOR
Intervention: Control group (comparison after-school program)
Number of subjects: 1563
Study 19157102 — intervention group
Group type: EXPERIMENTAL
Intervention: Vardenafil
Number of subjects: 39
Study 19157102 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 16941367 — intervention group
Group type: EXPERIMENTAL
Intervention: 23-valent pneumococcal polysaccharide vaccine (PPV)
Number of subjects: 11241
Study 14564262 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancellous impaction autografting with a 10-mm humeral component
Number of subjects: 10
Study 14564262 — intervention group
Group type: COMPARATOR
Intervention: Standard surgical technique without grafting
Number of subjects: 10
Study 10839209 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhodiola rosea extract SHR-5
Number of subjects: 0
Study 10839209 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9337947 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief cognitive therapy (BCT) plus 'treatment as usual'
Number of subjects: 48
Study 9337947 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 48
Study 9337947 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief cognitive therapy (BCT)
Number of subjects: 48
Study 8210821 — intervention group
Group type: EXPERIMENTAL
Intervention: Intent-to-treat analysis
Number of subjects: 0
Study 8210821 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclude non-adherers from analysis
Number of subjects: 0
Study 8210821 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer non-adherers to alternative treatment group at randomization
Number of subjects: 0
Study 8210821 — intervention group
Group type: EXPERIMENTAL
Intervention: Censor non-adherers at time of treatment change
Number of subjects: 0
Study 8210821 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer non-adherers to alternative treatment group at time of treatment change
Number of subjects: 0
Study 3320901 — intervention group
Group type: EXPERIMENTAL
Intervention: I.V. cefuroxime (1.5 g)
Number of subjects: 86
Study 3320901 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 30132465 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTA)
Number of subjects: 0
Study 30132465 — intervention group
Group type: EXPERIMENTAL
Intervention: Dysport
Number of subjects: 0
Study 27008297 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal 0.5% bupivacaine 3 mL with 2.5 µg dexmedetomidine
Number of subjects: 90
Study 27008297 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal 0.5% bupivacaine 3 mL with 5 µg dexmedetomidine
Number of subjects: 90
Study 27008297 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal 0.5% bupivacaine 3 mL with 10 µg dexmedetomidine
Number of subjects: 90
Study 25721889 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg
Number of subjects: 0
Study 25721889 — intervention group
Group type: COMPARATOR
Intervention: Esomeprazole
Number of subjects: 0
Study 23803871 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.54 mg/kg within 30 min)
Number of subjects: 27
Study 23803871 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 20107146 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (10 mg for infants, 20 mg for older children) for 4 months
Number of subjects: 2482
Study 20107146 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2482
Study 18382142 — intervention group
Group type: EXPERIMENTAL
Intervention: dTpa
Number of subjects: 0
Study 18382142 — intervention group
Group type: COMPARATOR
Intervention: DTPa
Number of subjects: 0
Study 18382142 — intervention group
Group type: COMPARATOR
Intervention: Td
Number of subjects: 0
Study 15871441 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 10 microg BID via Certihaler
Number of subjects: 265
Study 15871441 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 265
Study 15871441 — intervention group
Group type: COMPARATOR
Intervention: Albuterol 180 microg QID via pMDI
Number of subjects: 265
Study 14712886 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan (40 mg uptitrated to 80 mg after four weeks, if needed)
Number of subjects: 375
Study 14712886 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 375
Study 10646047 — intervention group
Group type: EXPERIMENTAL
Intervention: Racecadotril (100 mg three times daily)
Number of subjects: 70
Study 10646047 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 8910097 — intervention group
Group type: EXPERIMENTAL
Intervention: 3‐carbon compounds pyruvate and dihydroxyacetone (PD)
Number of subjects: 17
Study 8910097 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL, polyglucose)
Number of subjects: 17
Study 2052309 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact lens fundus biomicroscopy
Number of subjects: 20
Study 2052309 — intervention group
Group type: COMPARATOR
Intervention: Control eyes
Number of subjects: 20
Study 6488496 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzymatic estimates of myocardial infarct size based on plasma levels of MB creatine kinase (MB‐CK)
Number of subjects: 37
Study 6488496 — intervention group
Group type: COMPARATOR
Intervention: Control group (anatomic infarct size measurements)
Number of subjects: 37
Study 30891824 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 80
Study 30891824 — intervention group
Group type: COMPARATOR
Intervention: Sham electroacupuncture
Number of subjects: 80
Study 28013098 — intervention group
Group type: EXPERIMENTAL
Intervention: Prequit Nicotine Patch
Number of subjects: 637
Study 28013098 — intervention group
Group type: EXPERIMENTAL
Intervention: Prequit Nicotine Gum
Number of subjects: 637
Study 28013098 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparation Counseling
Number of subjects: 637
Study 28013098 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Cessation In‐Person Counseling
Number of subjects: 637
Study 28013098 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Cessation Telephone Counseling
Number of subjects: 637
Study 28013098 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 Weeks of Combination Nicotine Replacement Therapy (NRT)
Number of subjects: 637
Study 28013098 — intervention group
Group type: COMPARATOR
Intervention: 8 Weeks of Combination Nicotine Replacement Therapy (NRT)
Number of subjects: 637
Study 28013098 — intervention group
Group type: COMPARATOR
Intervention: Counseling Interventions
Number of subjects: 637
Study 27290960 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg dexketoprofen trometamol
Number of subjects: 60
Study 27290960 — intervention group
Group type: COMPARATOR
Intervention: 75 mg diclofenac sodium
Number of subjects: 60
Study 24398115 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage and stretching exercises
Number of subjects: 72
Study 24398115 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation and imagination therapies
Number of subjects: 72
Study 24398115 — intervention group
Group type: COMPARATOR
Intervention: Dental treatment
Number of subjects: 72
Study 22093943 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefitinib (GFT) 250mg/day continuously
Number of subjects: 59
Study 22093943 — intervention group
Group type: COMPARATOR
Intervention: Temozolomide (TMZ) 75mg/m² for 21/28 days
Number of subjects: 59
Study 20353109 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment in active stage group
Number of subjects: 40
Study 20353109 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment in resting stage group
Number of subjects: 40
Study 20353109 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment in recovery stage group
Number of subjects: 40
Study 17392541 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 152
Study 17392541 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study 15798682 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceramic veneering of fixed partial dentures (FPDs)
Number of subjects: 40
Study 15798682 — intervention group
Group type: COMPARATOR
Intervention: As-cast fixed partial dentures (FPDs)
Number of subjects: 40
Study 12090409 — intervention group
Group type: EXPERIMENTAL
Intervention: Intent‐to‐treat analysis
Number of subjects: 0
Study 12090409 — intervention group
Group type: EXPERIMENTAL
Intervention: Complier average causal effect estimation
Number of subjects: 0
Study 12090409 — intervention group
Group type: EXPERIMENTAL
Intervention: Monte Carlo simulations
Number of subjects: 0
Study 9861507 — intervention group
Group type: EXPERIMENTAL
Intervention: ComputerLink intervention (Wyse 30 terminals, online services including encyclopedia, communication, decision support)
Number of subjects: 57
Study 9861507 — intervention group
Group type: EXPERIMENTAL
Intervention: ComputerLink intervention
Number of subjects: 57
Study 9861507 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 57
Study 7617527 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannitol 0.755g/200ml
Number of subjects: 8
Study 7617527 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannitol 1.509g/200ml
Number of subjects: 8
Study 7617527 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannitol 2.264g/200ml
Number of subjects: 8
Study 7617527 — intervention group
Group type: COMPARATOR
Intervention: Control (radiolabelled purified water)
Number of subjects: 8
Study 2232833 — intervention group
Group type: COMPARATOR
Intervention: Standard hypothermic cardioplegic solution
Number of subjects: 14
Study 2232833 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardioplegic solution supplemented with deferoxamine 1000 mg/L
Number of subjects: 14
Study 758132 — intervention group
Group type: EXPERIMENTAL
Intervention: Propylthiouracil (PTU) 300 mg daily
Number of subjects: 124
Study 758132 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study 758132 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum T3-levels
Number of subjects: 124
Study 30522967 — intervention group
Group type: EXPERIMENTAL
Intervention: Regorafenib 160 mg once daily for the first 3 weeks of each 4-week cycle
Number of subjects: 119
Study 30522967 — intervention group
Group type: COMPARATOR
Intervention: Lomustine 110 mg/m2 once every 6 weeks
Number of subjects: 119
Study 30522967 — intervention group
Group type: EXPERIMENTAL
Intervention: Regorafenib
Number of subjects: 119
Study 30522967 — intervention group
Group type: COMPARATOR
Intervention: Lomustine
Number of subjects: 119
Study 29133648 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified hang-back lateral rectus recession with adjustable knot
Number of subjects: 0
Study 29133648 — intervention group
Group type: COMPARATOR
Intervention: Conventional hang-back recession with adjustable knot
Number of subjects: 0
Study 25193976 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Adaptation Training (CAT)
Number of subjects: 166
Study 25193976 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy for psychosis (CBTp)
Number of subjects: 166
Study 25193976 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-modal Cognitive treatment (combination of CBTp and CAT)
Number of subjects: 166
Study 25193976 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual
Number of subjects: 166
Study 23593645 — intervention group
Group type: EXPERIMENTAL
Intervention: G77-n (oven drying at 77°C, non-aging)
Number of subjects: 50
Study 23593645 — intervention group
Group type: EXPERIMENTAL
Intervention: G77-a (oven drying at 77°C, aging)
Number of subjects: 50
Study 23593645 — intervention group
Group type: EXPERIMENTAL
Intervention: GHF-n (etching with hydrofluoric acid 10% + rinsing with water at room temperature, non-aging)
Number of subjects: 50
Study 23593645 — intervention group
Group type: EXPERIMENTAL
Intervention: GHF-a (etching with hydrofluoric acid 10% + rinsing with water at room temperature, aging)
Number of subjects: 50
Study 23593645 — intervention group
Group type: EXPERIMENTAL
Intervention: G20-n (silanization, non-aging)
Number of subjects: 50
Study 23593645 — intervention group
Group type: EXPERIMENTAL
Intervention: G20-a (silanization, aging)
Number of subjects: 50
Study 21781528 — intervention group
Group type: EXPERIMENTAL
Intervention: Taxol and cisplatin combined chemotherapy (TP)
Number of subjects: 87
Study 20205024 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic/biological attributions of obesity
Number of subjects: 421
Study 17126116 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicaval orthotopic heart transplantation with DeVega tricuspid valve annuloplasty (TVA)
Number of subjects: 60
Study 17126116 — intervention group
Group type: COMPARATOR
Intervention: Standard bicaval orthotopic heart transplantation (STD)
Number of subjects: 60
Study 15266195 — intervention group
Group type: EXPERIMENTAL
Intervention: LISA-T prevention program (cognitive-behavioral therapy concepts, 10 meetings of 1.5 hours)
Number of subjects: 324
Study 15266195 — intervention group
Group type: COMPARATOR
Intervention: Nontreatment control group
Number of subjects: 324
Study 11438417 — intervention group
Group type: EXPERIMENTAL
Intervention: Fludarabine
Number of subjects: 0
Study 11438417 — intervention group
Group type: EXPERIMENTAL
Intervention: ChOP
Number of subjects: 0
Study 11438417 — intervention group
Group type: COMPARATOR
Intervention: CAP
Number of subjects: 0
Study 9150331 — intervention group
Group type: EXPERIMENTAL
Intervention: Home intravenous (i.v.) antibiotic therapy
Number of subjects: 17
Study 9150331 — intervention group
Group type: COMPARATOR
Intervention: Hospital therapy
Number of subjects: 17
Study 8429112 — intervention group
Group type: EXPERIMENTAL
Intervention: Zofenopril calcium (7.5 mg, 15 mg, 30 mg)
Number of subjects: 20
Study 8429112 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 3113280 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG) 10 mg four times daily
Number of subjects: 10
Study 3113280 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketotifen 1 mg twice daily
Number of subjects: 10